[{"Assets_0_Q3_USD":11895471000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":223157000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":223299000.0,"StockholdersEquityConverted_0_Q3_USD":764984000.0,"RevenuesConverted_3_Q3_USD":2700218000.0,"RevenuesConverted_1_Q3_USD":786887000.0,"NetIncomeLossConverted_3_Q3_USD":-1667016000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":223299000.0,"NetIncomeLossConverted_1_Q3_USD":-96670000.0,"EarningsPerShareDiluted_3_Q3_USD":-7.47,"EarningsPerShareDiluted_1_Q3_USD":-0.43,"EarningsPerShareBasic_3_Q3_USD":-7.47,"EarningsPerShareBasic_1_Q3_USD":-0.43,"CommonStockSharesOutstanding_0_Q3_shares":223301809.0,"CommonStockSharesConverted_0_Q3_shares":223301809.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":424062000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":223157000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]